Epigenetic Modifiers as Therapeutic Targets
GRIDS-2024 10th Anniversary CME Program

Start date: Jan 1, 2025
End date: Dec 31, 2025

Estimated time to complete: 1.25 hours

Credits: 1.25 AMA PRA Category 1 Credits™
Other Modules in this Series
Lysosomal & Rare Disorders Research & Treatment Center
GRIDS-2024 10th Anniversary CME Program
Epigenetic Modifiers as Therapeutic Targets
This activity was supported by educational grants from Lilly, Sanofi, Amicus and Takeda
Continuing Education Information
This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.
Learning Objectives
At the end of this activity, participants should be able to address one or more of the following:
- Analyze the development and delivery of ERT in neuronopathic Gaucher disease
- Understand the impact of the misfolding of the mutant glucocerebrosidase on the phenotypic heterogeneity of Gaucher disease.
Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, University of Ljubljana, Slovenia.
Ali Beskok, PhD
Associate Dean for Research Innovation and PhD Education George R. Brown Chair in Mechanical Engineering, Southern Methodist University, Texas, USA.
Ying Sun, Professor
Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Ohio, USA.
Majdolen Istaiti (Joleen), B.Sc., MBA
Clinical Study Coordinator at Gaucher Unit, Pediatric Hematology-Oncology Unit, Shaare Zedek Medical Center, Israel.
Faculty Disclosures
Dr. Katarina Trebušak Podkrajšek receives speaker fees and research support for Takeda Pharmaceuticals and research support from Swixx.
Dr. Ali Beskok has no relevant financial interest with an ineligible company to disclose.
Dr. Ying Sun receives research sponsorship from Enkefalos Bioscience, Yuhan Corporation, and Acelink Therapeutics. Dr. Sun also receives royalty payments from QPS Austria GmpH and Hangzhou Jiayin Biothech Ltd.
Ms Majdolen Istaiti has no relevant financial interest with an ineligible company to disclose.
Disclosures
AffinityCE staff, LDRTC staff, CheckRare CE staff, planners, and reviewers, have no relevant financial interests to disclose. All faculty disclosures are listed below and will be stated prior to the start of each session.
Mitigation of Relevant Financial Relationships
AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships reported have been mitigated prior to the commencement of the activity through peer review of content by non-conflicted reviewers.
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Continuing Nursing Education is provided for this program through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of 1.25 hours of continuing nursing education credit.
Nurse Practitioners
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Genetic Counselors
Category 2 CEU
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.
AffinityCE designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.
Other Professionals
All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.
Participation Costs
There is no cost to participate in this activity.
CME Inquiries
For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Send customer support requests to cds_support+ldrtc@affinityced.com.